The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...

Pepper, the pet cat who made headlines last year for his role in the discovery of the first jeilongvirus found in the U.S., ...

Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.

As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds—ticks.

Background Respiratory syncytial virus (RSV) remains the leading cause of serious viral bronchiolitis and pneumonia in infants and young children throughout the world. The burden of disease is ...

The Centers for Disease Control and Prevention's vaccine advisory committee voted on Thursday to recommend infants receive a newer monoclonal antibody shot for respiratory syncytial virus (RSV). The ...

Abstract Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory infections for which effective treatment options remain limited. Herein, we employed a computational ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Rather than creating a vaccine that mimics the RSV virus, they’re going straight to the source of protection: the immune cells that produce neutralizing antibodies. Antibodies start out as molecular ...

Introduction: Respiratory Syncytial Virus (RSV) is a significant cause of respiratory illnesses worldwide, particularly in infants and elderly individuals. Despite the burden RSV imposes, effective ...

RSV M protein interacts with host cell membranes, holding together the virus’s filamentous structure and coordinating viral components and other proteins — including RSV F proteins.